GenePOC obtains FDA clearance for its GenePOC™ Carba test in the USA
GenePOC announces FDA clearance of its molecular diagnostic test for the detection and differentiation of the five most frequent gene sequences associated with carbapenem-non-susceptibility. Read here the entire press release.